Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments ; volume:20 ; number:1 ; day:27 ; month:11 ; year:2017 ; pages:1-16 ; date:1.2018
The AAPS journal / American Association of Pharmaceutical Scientists ; 20, Heft 1 (27.11.2017), 1-16, 1.2018
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Urheber
-
Lauschke, Volker M.
- Beteiligte Personen und Organisationen
-
Milani, Lili
Ingelman-Sundberg, Magnus
SpringerLink (Online service)
- DOI
-
10.1208/s12248-017-0161-x
- URN
-
urn:nbn:de:1111-2018022320961
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lauschke, Volker M.
- Milani, Lili
- Ingelman-Sundberg, Magnus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments
A Landscape of Pharmacogenomic Interactions in Cancer
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments
A Landscape of Pharmacogenomic Interactions in Cancer
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments